The announcement focuses primarily on the effort to broaden and expand the marijuana research program, but this small clarification has opened several conversations.
Given the relatively new bill and the recent statement proclaimed by the DOJ and DEA, media outlets, business owners, and the general public are confused about the limitations and boundaries of hemp and CBD products.
Although the Attorney General did not explain the alteration in the classification of CBD and hemp (categorizing them with uncontrolled substances), the lack of research in marijuana and the hemp plant may have influenced his decision.
A controlled dose of CBD can stabilize the pain in a patient, removing any discomfort that typical treatments perhaps are not able to do.
The anti-inflammatory and painkilling properties found in CBD react with the human endocannabinoid system, producing an alleviation of chronic pain.
The success of the CBD treatment, especially within the elderly community, is revealed in the numbers. About 89% of elders using CBD in conjunction with pain medicine reported they would recommend this treatment to a friend.
However, many regulators still endorse an aura of caution around CBD, as shown by the FDA’s failure to approve the product for use in the food and pharmaceutical industries.
The FDA did approve the first drug containing CBD, Epidiolex, due to the drug’s overwhelming success. The drug has helped patients struggling with pediatric epilepsy and seizures.
Washington County of Nebraska authorized a raid on a store distributing and selling CBD products. Although the prosecutor sought felony drug charges three times, the judge for the case dismissed each attempt.
Most would be surprised to discover that CBD is not an addictive substance. On the contrary, CBD is used to battle addiction to other substances, such as alcohol, hardcore drugs (heroin, cocaines, etc.), and opioids.
Medical professionals, scientists, and other experts in the field claim that the human body naturally produces CBD in the endocannabinoid system to maintain balance during times of stress.
Therefore, people cannot possibly become addicted to the human body’s own naturally produced compound.
Theoretically, the human body can consume any amount of CBD without any possible form of addiction to the substance.
Predictions state that the CBD market could reach $20 billion by the year 2024, proving that CBD can become a mainstream product used throughout the United States and internationally as early as 2020.
Several factors are contributing to the formation and expansion of the CBD market, making it the next big investment opportunity. Some factors are the growing demand that substantially lowers the cost of the product and the involvement of other industries bringing in CBD to their products.
Different industries, such as wellness, cosmetics, and food and drink, have been infusing CBD into their lines of products.
From the Farm Bill of 2018 in the United States to the federal legalization of marijuana for recreational use in Canada, the boundaries of CBD have been pushed farther out in the last couple of years.
Even though the Department of Justice and DEA have withdrawn the legal substance’s classification as a controlled substance, research is being conducted to determine the future of CBD. So far, the future looks bright!